Exploring your options for Sickle Cell Disease in India? Ginger Healthcare brings together a carefully chosen panel of reputed hematologists, practising at world-class hospitals accredited by JCI and NABH. Request a free opinion and a cost estimate from any doctor on the list, and our team will guide you through every step of your journey.
Here are the most reputed doctors in India for Sickle Cell Disease Treatment. Each specialist is carefully vetted for their expertise, experience, and patient outcomes.
Here are the most reputed hospitals in India for Sickle Cell Disease Treatment. These hospitals are known for advanced infrastructure, international accreditations, and high success rates.
Sickle cell disease (SCD) is a lifelong inherited blood disorder in which abnormal haemoglobin causes red blood cells to become rigid and crescent-shaped, blocking small blood vessels and breaking down too quickly. This leads to episodes of severe pain (vaso-occlusive crises), chronic anaemia, and gradual damage to organs including the lungs, kidneys, brain, and spleen. Management ranges from daily medications and preventive care to chronic transfusion programmes and, for eligible patients, curative treatment through stem cell transplant or gene therapy. The right approach depends on disease type and severity, the patient's age, complication history, donor availability, and personal goals — and is planned in close partnership with a specialist haematologist.
Daily oral medication — primarily hydroxyurea — that increases fetal haemoglobin to reduce sickling, combined with preventive care such as vaccinations, folic acid, and regular haematologist monitoring.
Estimated cost: ~$200 – $500
Typical tests: Complete blood count (CBC) with differential and reticulocyte count, Haemoglobin HPLC or electrophoresis (if not recent), Fetal haemoglobin (HbF) level, Liver function tests (LFT), Kidney function tests (KFT) and urine protein, Serum ferritin and iron studies, Echocardiogram (to screen for pulmonary hypertension). Done in India before admission.
Estimated cost in India: $1,500 – $4,000
Treatment duration in India: ~3 weeks (~5 hospital visit days across the full span)
Regular blood transfusions — typically every 3-4 weeks — that dilute sickled cells with healthy donor red cells, used mainly for stroke prevention in children or management of severe recurring complications.
Estimated cost: ~$500 – $1,000
Typical tests: Complete blood count (CBC) with reticulocyte count, Extended red cell antigen phenotyping (Kell, Duffy, Kidd, Rh subtypes), Antibody screen and crossmatch, Serum ferritin and transferrin saturation, Liver MRI (T2*) for iron overload quantification, Liver and kidney function tests, Echocardiogram (pulmonary hypertension screen), Transcranial Doppler ultrasound (for children with HbSS or HbS-beta-zero). Done in India before admission.
Estimated cost in India: $2,000 – $6,000
Treatment duration in India: ~4 weeks (~10 hospital visit days across the full span)
A matched sibling's or close relative's stem cells replace the patient's own bone marrow, giving the body the ability to produce normal red blood cells — the most established curative option, best suited to children with a matched sibling donor.
Estimated cost in India: $20,000 – $45,000
For more details, visit: Bone Marrow Transplant (BMT) →
Uses a half-matched family donor (parent, sibling, or child) when a fully matched sibling is unavailable, expanding the pool of patients who can access a curative transplant — at higher complexity and cost.
Estimated cost in India: $35,000 – $45,000
For more details, visit: Haploidentical Bone Marrow Transplant →
From your first enquiry to recovery back home — we manage every detail so you can focus on getting better.
Join 5,000+ patients from 40+ countries who chose world-class care at a fraction of the cost.